Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2021-11-11 Investor Presentation
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
110年11月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing of scheduled investor presentations (法人說明會) with details such as company code, name, date, time, location, and summary of the presentation content. It includes links to presentation materials (PDF files) and mentions the company explaining recent operational results and future outlook. This matches the definition of an Investor Presentation (IP), which is a detailed presentation for investors focusing on financials, strategy, and market position. The document is not a full report, audit, or announcement of voting results, but rather information about an investor meeting and its materials.
2021-11-11 Chinese
110年10月營業收入
Regulatory Filings Classification · 95% confidence The document is a revenue summary report for a company named 杏輝, showing monthly and cumulative net operating revenue figures with comparisons to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document is short (772 characters) and primarily provides summarized financial data without detailed financial statements or management discussion. It does not appear to be a full annual or interim report, nor an earnings release or investor presentation. It is a regulatory disclosure of summarized financial data, typical of a general regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS).
2021-11-09 Chinese
110年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company 杏輝, providing details on fund lending balances and endorsement guarantees for the current and previous months, including cumulative amounts and limits. The content is a regulatory disclosure of financial guarantees and related party transactions, typical of a regulatory announcement rather than a full financial report. The document length is short (624 characters), and it does not contain comprehensive financial statements or management discussion. It is not an announcement of a report publication but a direct regulatory disclosure. Therefore, it fits best under Regulatory Filings (RNS).
2021-11-09 Chinese
本公司董事會決議通過110年度 第三季合併財務報告案
Interim / Quarterly Report Classification · 95% confidence The document is a formal announcement from the company's board regarding the approval of the third quarter consolidated financial report for the fiscal year 110 (which corresponds to 2021 in the Gregorian calendar). It includes specific financial data such as revenue, gross profit, operating loss, net loss, total assets, liabilities, and equity for the period from January 1 to September 30. The document is relatively short (919 characters) and is structured as a regulatory announcement of the board's resolution to approve the quarterly financial report rather than the full report itself. It contains substantive financial data for a period shorter than a full fiscal year, indicating it is an Interim / Quarterly Report. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2021-11-02 Chinese
本公司受邀參加華南永昌綜合證券舉辦之法人說明會
Investor Presentation Classification · 95% confidence The document is a brief announcement about the company (杏輝) being invited to participate in an investor presentation hosted by a securities firm. It includes details such as date, time, location, and a summary that the company will discuss recent operational results and future outlook. The document length is very short (678 characters), and it does not contain actual financial statements or detailed financial data. It is clearly an announcement of an upcoming investor presentation event rather than the presentation itself or a financial report. Therefore, the appropriate classification is Investor Presentation (IP).
2021-11-02 Chinese
因本公司有價證券於集中交易市場達公布注意交易資訊標準 故公布相關財務業務等重大訊息，以利投資人區別瞭解。
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a listed company (杏輝) disclosing recent financial and business information due to reaching a threshold for attention trading information as per Taiwan Stock Exchange requirements. It includes recent monthly and quarterly financial figures, notes that the latest monthly figures are unaudited, and references recent significant announcements and trading suspensions related to a subsidiary. The document is short (1912 characters) and primarily serves to inform investors of recent financial data and related events, with instructions to find full financial reports elsewhere. It does not contain a full annual or interim report, detailed management discussion, nor is it a transcript or presentation. It is an official regulatory disclosure of material information but not a full report itself. Therefore, it fits best under Regulatory Filings (RNS).
2021-10-27 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.